[New indication for 6-azauridine triacetate--psoriasis].
D000085:Acetates / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D009705:Nucleosides / Q000627:therapeutic use*; D010919:Placebos; D011565:Psoriasis / Q000188:drug therapy*
D000085:Acetates; D000963:Antimetabolites; D009705:Nucleosides; D010919:Placebos
Nová indikace pro 6-azauridin triacetát--psoriáza.